Ugur Sahin, co-founder of company that jointly developed leading COVID-19 inoculation, says shots have proved effective against other similar mutations
As the German biotechnology firm worked on a shot to defeat virus, other companies around the country already began organizing the infrastructure needed to deliver it to billions
Head of German pharmaceutical company says it will take another two weeks to get enough data to know for sure if inoculation effective against more contagious mutated strain
Recent comments